Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) EBT Margin (2016 - 2025)

Historic EBT Margin for Bio Key International (BKYI) over the last 17 years, with Q3 2025 value amounting to 62.26%.

  • Bio Key International's EBT Margin fell 278100.0% to 62.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 67.71%, marking a year-over-year increase of 86200.0%. This contributed to the annual value of 62.39% for FY2024, which is 492200.0% up from last year.
  • According to the latest figures from Q3 2025, Bio Key International's EBT Margin is 62.26%, which was down 278100.0% from 68.8% recorded in Q2 2025.
  • Bio Key International's EBT Margin's 5-year high stood at 23.39% during Q1 2024, with a 5-year trough of 387.25% in Q4 2022.
  • For the 5-year period, Bio Key International's EBT Margin averaged around 109.4%, with its median value being 88.28% (2022).
  • Its EBT Margin has fluctuated over the past 5 years, first surged by 6441900bps in 2021, then crashed by -1734300bps in 2022.
  • Bio Key International's EBT Margin (Quarter) stood at 213.81% in 2021, then crashed by -81bps to 387.25% in 2022, then surged by 63bps to 145.18% in 2023, then surged by 34bps to 96.25% in 2024, then surged by 35bps to 62.26% in 2025.
  • Its EBT Margin stands at 62.26% for Q3 2025, versus 68.8% for Q2 2025 and 45.83% for Q1 2025.